Literature DB >> 3313489

Medical care utilization and the transcendental meditation program.

D Orme-Johnson1.   

Abstract

This field study compared 5 years of medical insurance utilization statistics of approximately 2000 regular participants in the Transcendental Meditation (TM) program with a normative data base of approximately 600,000 members of the same insurance carrier. The benefits, deductible, coinsurance terms, and distribution by gender of the TM group were very similar to the norm, yet the TM group had lower medical utilization rates in all categories. Inpatient days per 1000 by age category were 50.2% fewer than the norm for children (0-18), 50.1% fewer for young adults (19-39), and 69.4% fewer for older adults (40+). Outpatient visits per 1000 for the same age categories were, respectively, 46.8%, 54.7%, and 73.7% fewer. When compared with five other health insurance groups of similar size and professional membership, the TM group had 53.3% fewer inpatient admissions per 1000 and 44.4% fewer outpatient visits per 1000. Admissions per 1000 were lower for the TM group than the norm for all of 17 major medical treatment categories, including -55.4% for benign and malignant tumors -87.3% for heart disease, -30.4% for all infectious diseases, -30.6% for all mental disorders, and -87.3% for diseases of the nervous system. However, the TM group's admission rates for childbirth were similar to the norm. The issue of self-selection is addressed in terms of previous medical research in this area.

Entities:  

Mesh:

Year:  1987        PMID: 3313489     DOI: 10.1097/00006842-198709000-00006

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  22 in total

1.  Disease prevention and health promotion in the aging with a traditional system of natural medicine: Maharishi Vedic Medicine.

Authors:  Robert H Schneider; Charles N Alexander; John W Salerno; Donald K Robinson; Jeremy Z Fields; Sanford I Nidich
Journal:  J Aging Health       Date:  2002-02

2.  Ayurvedic medicine.

Authors: 
Journal:  CMAJ       Date:  1991-07-01       Impact factor: 8.262

3.  Treatment of fibromyalgia at the Maharishi Ayurveda Health Centre in Norway II--a 24-month follow-up pilot study.

Authors:  Lars Bjørn Rasmussen; Knut Mikkelsen; Margaretha Haugen; Are H Pripp; Jeremy Z Fields; Øystein T Førre
Journal:  Clin Rheumatol       Date:  2012-01-27       Impact factor: 2.980

4.  Transcending Humiliation: An ancient perspective.

Authors:  P J Barrett; J S Brooks
Journal:  J Prim Prev       Date:  1992-03

5.  Alternative and complementary medicine for asthma.

Authors:  D J Lane; T V Lane
Journal:  Thorax       Date:  1991-11       Impact factor: 9.139

6.  Clinical and Pre-clinical Applications of the Transcendental Meditation Program in the Prevention and Treatment of Essential Hypertension and Cardiovascular Disease in Youth and Adults.

Authors:  Vernon A Barnes; David W Orme-Johnson
Journal:  Curr Hypertens Rev       Date:  2006-08-01

Review 7.  Cardiovascular disease prevention and health promotion with the transcendental meditation program and Maharishi consciousness-based health care.

Authors:  Robert H Schneider; Kenneth G Walton; John W Salerno; Sanford I Nidich
Journal:  Ethn Dis       Date:  2006       Impact factor: 1.847

Review 8.  Improvements in chronic diseases with a comprehensive natural medicine approach: a review and case series.

Authors:  T Nader; S Rothenberg; R Averbach; B Charles; J Z Fields; R H Schneider
Journal:  Behav Med       Date:  2000       Impact factor: 3.104

9.  Prevention and Treatment of Cardiovascular Disease in Adolescents and Adults through the Transcendental Meditation(®) Program: A Research Review Update.

Authors:  Vernon A Barnes; David W Orme-Johnson
Journal:  Curr Hypertens Rev       Date:  2012-08

10.  Elevated serum dehydroepiandrosterone sulfate levels in practitioners of the Transcendental Meditation (TM) and TM-Sidhi programs.

Authors:  J L Glaser; J L Brind; J H Vogelman; M J Eisner; M C Dillbeck; R K Wallace; D Chopra; N Orentreich
Journal:  J Behav Med       Date:  1992-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.